Skip to main content

HR 7953

To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities

In Committeeforeign policyhealthcare

Progress

Timeline

  • Mar 17Referred to the House Committee on Energy and Commerce.

How This Affects You

Sign up to see how this bill affects you personally

Already have an account? Log in

View on Congress.gov

Get personalized insights on this bill

CivicRadar tells you exactly how government actions affect your life based on your location, interests, and profession.